News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
360,764 Results
Type
Article (10769)
Company Profile (214)
Press Release (349781)
Section
Business (110958)
Career Advice (319)
Deals (19399)
Drug Delivery (33)
Drug Development (44494)
Employer Resources (64)
FDA (8939)
Job Trends (8456)
News (185140)
Policy (13972)
Tag
Academia (1209)
Alliances (30356)
Alzheimer's disease (662)
Approvals (8940)
Artificial intelligence (98)
Bankruptcy (105)
Best Places to Work (7456)
Biotechnology (143)
Breast cancer (72)
Cancer (694)
Cardiovascular disease (58)
Career advice (285)
Cell therapy (143)
Clinical research (36968)
Collaboration (311)
Compensation (121)
COVID-19 (874)
C-suite (79)
Data (807)
Diabetes (79)
Diagnostics (3185)
Earnings (40199)
Employer resources (56)
Events (61608)
Executive appointments (261)
FDA (9334)
Featured Employer (54)
Funding (263)
Gene therapy (89)
GLP-1 (219)
Government (1498)
Healthcare (9893)
Infectious disease (917)
Inflammatory bowel disease (60)
IPO (9417)
Job creations (1332)
Job search strategy (257)
Layoffs (120)
Legal (2316)
Lung cancer (108)
Manufacturing (120)
Medical device (8783)
Medtech (8785)
Mergers & acquisitions (10162)
Metabolic disorders (188)
Neuroscience (825)
NextGen Class of 2024 (3172)
Non-profit (2353)
Northern California (983)
Obesity (94)
Opinion (86)
Patents (66)
People (33828)
Pharmaceutical (58)
Phase I (10943)
Phase II (16178)
Phase III (12686)
Pipeline (315)
Postmarket research (1046)
Preclinical (3971)
Radiopharmaceuticals (198)
Rare diseases (115)
Real estate (3085)
Regulatory (10785)
Research institute (1261)
Southern California (878)
Startups (2104)
United States (9138)
Vaccines (172)
Date
Today (55)
Last 7 days (473)
Last 30 days (2624)
Last 365 days (24665)
2024 (22638)
2023 (26582)
2022 (32406)
2021 (34688)
2020 (32113)
2019 (27764)
2018 (20574)
2017 (19638)
2016 (17932)
2015 (20818)
2014 (15094)
2013 (11893)
2012 (12433)
2011 (12171)
2010 (10742)
Location
Africa (278)
Arizona (63)
Asia (23837)
Australia (3088)
California (2208)
Canada (776)
China (214)
Colorado (110)
Connecticut (112)
Delaware (54)
Europe (52569)
Florida (310)
Georgia (84)
Illinois (220)
Indiana (153)
Japan (54)
Kansas (67)
Maryland (336)
Massachusetts (1761)
Michigan (92)
Minnesota (179)
New Jersey (776)
New York (723)
North Carolina (511)
Northern California (983)
Ohio (104)
Pennsylvania (583)
South America (425)
Southern California (878)
Texas (303)
Washington State (169)
360,764 Results for "innovate biopharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biopharmaceutical Market Size to Reach USD 643.9 Billion by 2032, Impelled by Advancements in Biotechnology
Biopharmaceutical Market Outlook 2024-2032:
August 1, 2024
·
9 min read
Press Releases
Biopharmaceuticals Market to Hit US$ 654.76 Billion by 2030, Coherent Market Insights
November 13, 2024
·
1 min read
Press Releases
Monoclonal Antibody Therapeutics Market Size to Reach USD 919.06 Billion by 2033, Propelled by Pioneering Innovations in Biopharmaceutical Engineering
July 24, 2024
·
14 min read
Sanyou Biopharmaceuticals Launches Advanced Intelligent R&D Service Platform
Sanyou Biopharmaceutical Co., Ltd. is delighted to announce the official launch of the “Sanyou Intelligent Innovative Biologics R&D Service Platform,” representing a transformative advancement in biopharmaceutical research and development.
March 12, 2024
·
2 min read
China
Pfizer Makes $1B Commitment in China to Boost Innovation, Targets Chinese Market
The five-year investment will go toward the construction of a new R&D facility in Beijing to develop innovative therapies and integrate the world’s second most populated country into the company’s global strategy.
November 8, 2024
·
2 min read
·
Tristan Manalac
Pharm Country
Outlook Therapeutics® to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment of retinal diseases in the US and the EU, today announced it will present at the OIS Retina Innovation Showcase being held May 4, 2024 in Seattle, WA.
April 29, 2024
·
1 min read
Press Releases
Pharvaris to Participate in the Guggenheim Healthcare Innovation Conference
November 12, 2024
·
1 min read
Press Releases
Provectus Biopharmaceuticals Announces Fourth Quarter 2024 Conference Call
October 10, 2024
·
3 min read
Deals
Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals
Sentynl Therapeutics, Inc. (Sentynl) and Eiger BioPharmaceuticals, Inc. (OTC: EIGRQ), a commercial-stage biopharmaceutical company focused on the development of innovative therapies for rare metabolic diseases, today announced the closing of the sale of Eiger’s Zokinvy® (lonafarnib) program to Sentynl.
May 3, 2024
·
11 min read
Diabetes
Innovent’s Lilly-Partnered Type 2 Diabetes Drug Aces Phase III in China, Inches Closer to Approval
Innovent Biologics’ dual GLP-1/glucagon receptor agonist mazdutide is also being developed for chronic weight management. China’s regulator accepted Innovent’s drug application for this indication in February 2024.
July 22, 2024
·
2 min read
·
Tristan Manalac
1 of 36,077
Next
